Assessment of the Appropriateness of Antituberculosis Drug Utilization in Pulmonary Tuberculosis Patients
Abstract
Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, primarily affects the lungs. This study aims to evaluate the precise use of antituberculosis drugs, focusing on factors such as patient suitability, correct indication, drug selection, dosage, administration method, and treatment duration. Sampling involved Purposive Sampling of pulmonary tuberculosis outpatients Dr. RSUD. H. Abdul Moeloek Bandar Lampung from January to December 2021, resulting in 89 patients. The data showed a majority of male patients, with 52 (58.4%) aged between 36 and 45 years, and 24 (26.9%) weighing between 46 kg and 55 kg. Additionally, 50 patients (56%) tested positive for sputum BTA and had undergone category I treatment previously. Evaluation of antituberculosis drug usage in these outpatients revealed 100% accuracy in patient suitability, indication, drug selection, dosage, and administration method, with a treatment duration of 15 days. Hence, it can be inferred that the utilization of antituberculosis drugs is appropriate.
Copyright (c) 2024 JOPS (Journal Of Pharmacy and Science)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. Copyright of all journal manuscripts is held by the JOPS (Journal Of Pharmacy and Science)
2. Formal legal provisions to access digital articles of electronic journal are subject to the provision of the Creative Commons Attribution-ShareAlike license (CC BY-NC-SA), which means that JOPS (Journal Of Pharmacy and Science) is rightful to keep, transfer media/format, manage in the form of databases, maintain, and publish articles.
3. Published manuscripts both printed and electronic are open access for educational, research, and library purposes. Additiponally, the editorial board is not responsible for any violations of copyright law.
licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.